Frédéric Davi

发表

The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype.

J. Cayuela, E. Macintyre, F. Davi, 2000, Blood.

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

T. Molina, P. Gaulard, M. Tiemann, 2007, Leukemia.

The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia

F. Berger, R. Berger, O. Bernard, 2008, Leukemia.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

K. Stamatopoulos, D. Rossi, G. Gaidano, 2018, Leukemia.

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

K. Stamatopoulos, R. Rosenquist, S. Stilgenbauer, 2007, Leukemia.

Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies

P. Debré, C. Dutertre, F. Davi, 2011, Leukemia.

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

E. Schuuring, J. V. van Dongen, E. Macintyre, 2012, Leukemia.

Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of surface CD23 antigen.

F. Mentz, M. D. Mossalayi, F. Ouaaz, 1994, Blood.

Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1

P. Feugier, S. Leprêtre, F. Davi, 2017, Leukemia.